Dr. Reddy`s Laboratories Overview
Dr. Reddy`s Laboratories (RDY) has a P/E ratio of 29.34, above the Healthcare sector average of 24.78.
Get informed when a big investor buys or sells
+ Follow29.34
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
As of the most recent data, RDY shows a P/E ratio of 29.34. That is above the Healthcare sector average of 24.78. Scroll down for historical charts and peer comparison views.
The Healthcare sector average P/E ratio is about 24.78. Dr. Reddy`s Laboratories is at 29.34, which is higher that average. That is roughly 18.4% above the sector mean. Use the comparison chart on this page to see how RDY stacks up against individual peers as well.
Investors watch RDY's P/E ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Dr. Reddy`s Laboratories's latest reading is 29.34. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this p/e ratio page, Stockcircle has Dr. Reddy`s Laboratories's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/E ratio (currently 29.34) with ownership activity and broader fundamentals.
The Healthcare average P/E ratio is about 24.78, while RDY is at 29.34. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
